Homo sapiens (human)
| UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
|---|---|---|---|---|---|
| I3VZ22 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
| Q9UGM5 | Fetuin-B |
|
9 | 33 |
|
| Q99638 | Cell cycle checkpoint control protein RAD9A |
|
1 | 0 |
|
| Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 |
|
2 | 0 |
|
| Q86U28 | Iron-sulfur cluster assembly 2 homolog, mitochondrial |
|
1 | 0 | |
| Q9BYJ0 | Fibroblast growth factor-binding protein 2 |
|
10 | 3 |
|
| Q9BUJ2 | Heterogeneous nuclear ribonucleoprotein U-like protein 1 |
|
14 | 2 |
|
| Q9BTV4 | Transmembrane protein 43 |
|
1 | 1 | |
| G1ENV3 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
| P36956 | Sterol regulatory element-binding protein 1 |
|
3 | 1 | |
| Q13310 | Polyadenylate-binding protein 4 |
|
2 | 1 |
|
| B2R6U9 | Delta-like protein |
|
3 | 0 |
|
| Q13607 | Olfactory receptor 2F1 |
|
1 | 0 |
|
| G1ENX4 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
| H7BZ55 | Ciliary rootlet coiled-coil protein 2 |
|
4 | 1 |
|
| Q86WN2 | Interferon epsilon |
|
2 | 0 |
|
| D3U414 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
| Q5VZ89 | DENN domain-containing protein 4C |
|
4 | 1 |
|
| H0YCG2 | Lysosomal associated membrane protein 2 (Fragment) |
|
2 | 0 |
|
| D5L9D9 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
| A0A0B4J240 | T cell receptor alpha variable 10 |
|
2 | 0 |
|
| Q8TED1 | Probable glutathione peroxidase 8 |
|
1 | 1 |
|
| Q9NQX5 | Neural proliferation differentiation and control protein 1 |
|
13 | 2 |
|
| Q07666 | KH domain-containing, RNA-binding, signal transduction-associated protein 1 |
|
12 | 1 |
|
| Q5PY19 | Transforming growth factor beta 1 (Fragment) |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025